Enanta Pharmaceuticals Inc. (ENTA)
NASDAQ · Healthcare
Enanta Pharmaceuticals Inc. Total Liabilities 2020–2025
Enanta Pharmaceuticals Inc. annual total liabilities history from 2020 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Enanta Pharmaceuticals Inc. total liabilities as of September 30, 2025: 216.0M, a 12.84% decrease year-over-year.
- Enanta Pharmaceuticals Inc. total liabilities for 2025 were 216.0M, a 12.84% decrease from 2024.
- Enanta Pharmaceuticals Inc. total liabilities for 2024 were 247.8M, a 0.94% increase from 2023.
- Enanta Pharmaceuticals Inc. total liabilities for 2023 were 245.5M, a 354.06% increase from 2022.
- Enanta Pharmaceuticals Inc. total liabilities for 2022 were 54.1M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Enanta Pharmaceuticals Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $216 |
| 2024 | $248 |
| 2023 | $246 |
| 2022 | $54 |
| 2021 | $39 |
| 2020 | $31 |
Enanta Pharmaceuticals Inc. Total Liabilities — FAQ
Enanta Pharmaceuticals Inc. (ENTA) total liabilities over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ENTA's total liabilities history?
The chart and table above show Enanta Pharmaceuticals Inc.'s total liabilities by year and by quarter, including the growth rate.